The CRIS Shared Resource serves as both a medical informatics and as a.service core. It consists of four main components: the Massey Cancer Center Information System (MCCIS), the Automated Cancer Extraction (ACE) Application, the Clinical Trials Eligibility Database (CTED), and the clinical research database system (Oncore?). With the exception of Oncore?, each component has been developed at VCU and is linked both technologically in terms of interrelated data sources and software as well as functionally in terms of personnel and services provided. The system design is based on inter-operability and community standards, with potential extensibility a strong development consideration. The core data come from linkage of multiple electronic sources across the VCU health care system including: inpatient and outpatient facilities, and the MCC In addition, primary data entered by research staff are a component of the CTED and Oncore?. The data from the core are available and downloadable both as source documents (such as original surgical pathology reports) and as analyzable datasets developed by core personnel to answer specific research questions. In addition to the data, consultative and analytic services are provided through this Shared Resource. These services range from providing population numbers for grant preparation to linkage and analysis of complex data sets developed in response to investigator requests. The MCCIS is the oldest component of the core, originally developed in 1998, with the linkage of VCU claims data for inpatient and outpatient services. The MCCIS serves as the primary component providing analysis services, linking and utilizing data from the MCCIS and the other three core components for these analyses. The ACE application is the newest component and was implemented in December of 2006. ACE serves as the initial processing system for screening messages for cancer relevance and for storage of all electronic sources from the VCUHS and linking the data to CTED and the hospital cancer registry. The most recent SQL Server version of CTED was implemented in April of 2007. The commercial application used for administrative and clinical research in tracking of oversight and clinical trials activity was implemented in 2005. Currently, integration and equivalency of Oncore? with the other three components is being developed to provide autouploading of key information such as demographics, as well as direct access to source documentation from the other three components of CRIS for research staff while in the Oncore? environment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016059-29
Application #
7826930
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
29
Fiscal Year
2009
Total Cost
$65,136
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Yamada, Akimitsu; Nagahashi, Masayuki; Aoyagi, Tomoyoshi et al. (2018) ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer. Mol Cancer Res 16:1059-1070
Cantwell, Marc T; Farrar, Jared S; Lownik, Joseph C et al. (2018) STAT3 suppresses Wnt/?-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis. Cytokine 111:434-444
Aqbi, Hussein F; Wallace, Matthew; Sappal, Samay et al. (2018) IFN-? orchestrates tumor elimination, tumor dormancy, tumor escape, and progression. J Leukoc Biol :
Volker, Sonja E; Hedrick, Shannon E; Feeney, Yvonne B et al. (2018) Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland. Cancer Res 78:3877-3887
Li, Xiaojiaoyang; Liu, Runping; Huang, Zhiming et al. (2018) Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology 68:599-615
Durant, Stephen T; Zheng, Li; Wang, Yingchun et al. (2018) The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv 4:eaat1719
Damle, S R; Martin, R K; Cockburn, C L et al. (2018) ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production. Allergy 73:125-136
Wang, Feng; Li, Hongyan; Markovsky, Ela et al. (2018) Pazopanib radio-sensitization of human sarcoma tumors. Oncotarget 9:9311-9324
Stokes, Nancy A; Stanciu, Cristina E; Brocato, Emily R et al. (2018) Simplification of complex DNA profiles using front end cell separation and probabilistic modeling. Forensic Sci Int Genet 36:205-212
Poklepovic, Andrew; Qu, Yuesheng; Dickinson, Molly et al. (2018) Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers. Cardiooncology 4:

Showing the most recent 10 out of 586 publications